Site Management/Investigator Payments Featured Articles

  1. Tekton's CEO On The Growing Power Of Site Networks 2/27/2026

    Site networks continue to gain momentum as organizations emphasize operational consistency, shared infrastructure, and scale. Tekton Research CEO Corey Collins discusses how collaboration, sponsor dialogue, and real-world pressures like recruitment challenges and study delays are shaping the model — while it remains too early to know whether network-scale approaches will deliver meaningful efficiencies for sponsors.

  2. The Cost Of Transactional Thinking In Clinical Research 2/26/2026

    Denise N. Bronner of Empactful Ventures explores the power dynamics at play in clinical research, picking apart the roles of sponsors, vendors, and sites and advocating for a better way to do business among them.

  3. Say It Loud: Clinical Research Needs New Voices 2/26/2026

    At SCOPE, I caught up with Denali Rose, co-host of the Note to File podcast, to talk about why clinical research still struggles to communicate — and why that has to change. She’s pushing for more honest conversations and new voices across sponsors, sites, and vendors, and while progress is slow, she sees signs the silos are finally starting to crack.

  4. Site-Centric First, Patient-Centric Always 2/25/2026

    At the 2026 SCOPE Summit, Boehringer Ingelheim’s Wouter Daniels argued that true patient centricity begins with site centricity. Daniels shared how Boehringer’s engagement efforts have accelerated studies by months and saved millions — proof that patient focus delivers measurable business and operational value.

  5. Why Sponsors Should Share KPI Rationale With Sites 2/25/2026

    To build partnerships, foster transparency, and promote shared accountability, Curo Research CEO Amy Bland explains why sponsors need to communicate the utility of KPIs with sites.

  6. From Standards To Study Conduct: The Operational Reality Of RBQM 2/22/2026

    Operationalizing risk-based quality management requires early identification of critical-to-quality factors, cross-functional collaboration, integrated systems, and a cultural shift toward proactive, proportionate trial oversight.

  7. Joe Dustin: Sites Are Driving Clinical Tech Evolution 2/20/2026

    At SCOPE Summit 2026, Joe Dustin shared why clinical trial sites are emerging as the next drivers of innovation. As sites digitize operations and push back against the burden of sponsor-mandated systems, new models like “bring your own technology” and seamless digital data flow aim to reduce duplication, speed startup, and improve both coordinator and patient experiences.

  8. How To Lead A Moonshot Collaboration: Lessons From Over A Decade Of Competitors Working Together 2/3/2026

    TransCelerate BioPharma's Andy Lee and Janice Change share the lessons they learned bringing disparate voices together for a united purpose.

  9. The U.S. Trial Advantage Is Eroding 1/30/2026

    Once the go-to location for trials, the U.S. is now seeing competition from APAC, driven by political, economic, and workforce pressures domestically and rapid growth abroad.

  10. Too Little Info, Too Much Time Wasted: Feasibility Challenges For Sites 1/27/2026

    Incomplete protocols, lengthy sponsor decision timelines, and uncompensated work plague clinical research sites. Learn why these issues exist and how to address them alongside experts from SCRS and Tufts CSDD.